No products in the cart.
Zytiga x 120
$116.73
Zytiga is a medication available in the form of a 250mg tablet. It is primarily used in the treatment of prostate cancer that has spread to other parts of the body. The active ingredient in Zytiga is abiraterone acetate, which works by inhibiting the production of certain hormones that fuel the growth of prostate cancer cells. By blocking these hormones, Zytiga helps slow down the progression of the disease and may improve overall survival rates. Zytiga is typically prescribed in combination with other medications and under the supervision of a healthcare professional. It is important to follow the prescribed dosage and any accompanying instructions provided by the healthcare provider while taking Zytiga.
ChatGPT
Zytiga is a medication available in the form of a 250mg tablet. The active ingredient in Zytiga is abiraterone acetate. It is primarily used in the treatment of prostate cancer that has spread to other parts of the body and is resistant to other forms of treatment.
Zytiga belongs to a class of drugs called androgen biosynthesis inhibitors. It works by inhibiting an enzyme called CYP17, which is involved in the production of androgens (male hormones) such as testosterone. By blocking this enzyme, Zytiga reduces the levels of androgens in the body, which can help slow down the growth of prostate cancer cells.
Usage Information: Zytiga is typically prescribed in combination with prednisone or prednisolone, which are corticosteroid medications. The combination helps to manage certain side effects and optimize the effectiveness of Zytiga.
The usual recommended dose of Zytiga is 1,000mg (four 250mg tablets) taken once daily on an empty stomach, at least one hour before or two hours after eating. Prednisone or prednisolone is usually taken alongside Zytiga, as prescribed by the healthcare provider.
It’s important to follow the dosing instructions provided by the doctor or pharmacist and not alter the dosage without medical guidance. Zytiga tablets should be swallowed whole with water, without crushing, chewing, or splitting them.
Side Effects: Like any medication, Zytiga can cause side effects. Common side effects may include fatigue, joint or muscle pain, hot flashes, diarrhea, nausea, vomiting, constipation, high blood pressure, fluid retention, urinary tract infection, and headache.
More serious side effects, although rare, may include liver problems, heart problems, adrenal insufficiency, allergic reactions, and bone marrow suppression. If any severe or persistent side effects occur, it is important to seek medical attention promptly.
It’s essential to discuss any existing medical conditions, allergies, or medications with a healthcare provider before starting Zytiga, as it may interact with other drugs or exacerbate certain conditions.
Regular monitoring and follow-up appointments with the healthcare provider are crucial to evaluate the response to treatment and manage any potential side effects effectively.
| Weight | 0.06 kg |
|---|---|
| Dimensions | 3 × 3 × 1 cm |
Related products
$116.73
Venclexta is a prescription medication that comes in tablet form. It is used in the treatment of certain types of cancer, specifically chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Venclexta belongs to a class of drugs called BCL-2 inhibitors, which work by blocking a protein called BCL-2 that helps cancer cells survive. By inhibiting this protein, Venclexta helps to promote programmed cell death, also known as apoptosis, in cancer cells, leading to the reduction or elimination of cancerous cells. Venclexta is typically used in combination with other cancer treatments and is only available with a doctor's prescription.
$116.73
Zavedos is a medication available in the form of a 10mg capsule. It is primarily used in the treatment of certain types of cancer, including acute myeloid leukemia (AML). The active ingredient in Zavedos is idarubicin, which belongs to a class of drugs called anthracyclines. Idarubicin works by inhibiting the growth of cancer cells and preventing their replication. Zavedos is typically administered under the supervision of a healthcare professional in a hospital or clinical setting. It is an important tool in the fight against cancer, offering hope and potential relief for patients with AML.